Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Ovarian Cancer,2016,NCI,1K22CA193860-01,,"PCOS, Type II diabetes and ovarian cancer risk","HARRIS, HOLLY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$184,615"
Ovarian Cancer,2016,NCI,1R35CA197605-01,,Mucins and immune cell interactions in ovarian cancer pathogenesis & progression,"CRAMER, DANIEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$1,052,893"
Ovarian Cancer,2016,NIAID,5R01AI033993-22,,Processed Antigen Characterization by Mass Spectrometry,"HUNT, DONALD",UNIVERSITY OF VIRGINIA,VA,"$624,957"
Ovarian Cancer,2016,NCI,5R01CA043054-29,,Nuclear Function of Abl in DNA Damage Response,"WANG, JEAN",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$387,500"
Ovarian Cancer,2016,NCI,5R01CA135650-07,,Predictive Cancer Diagnostics and Therapy Response,"MOORE, ANNA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$552,368"
Ovarian Cancer,2016,NCI,4R01CA158415-05,,Heterocellular 3D ovarian tumor arrays for imaging and mechanistic combinations,"HASAN, TAYYABA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$367,787"
Ovarian Cancer,2016,NCI,4P30CA006516-51,6051,Gynecologic Cancers,"BIRRER, MICHAEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$93,366"
Ovarian Cancer,2016,NCI,4P30CA006516-51,6064,Cancer Epidemiology,"HANKINSON, SUSAN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$82,450"
Ovarian Cancer,2016,NCI,5R21CA185808-02,,Genetic Testing For Men From Hereditary Cancer Families,"SCHWARTZ, MARC",GEORGETOWN UNIVERSITY,DC,"$169,106"
Ovarian Cancer,2016,NCI,5R00CA168987-04,,Discovering genomic rearrangements under selection in serious ovarian cancer,"SALZMAN, JULIA",STANFORD UNIVERSITY,CA,"$227,841"
Ovarian Cancer,2016,NCI,5R03CA184394-02,,Intraperitoneal Delivery of Targeted Nanoparticles for Metastatic Ovarian Cancer,"LU, XIULING",UNIVERSITY OF CONNECTICUT STORRS,CT,"$79,000"
Ovarian Cancer,2016,NCI,4R01CA097061-13,,Chemical genetic profiling of engineered tumor cells,"STOCKWELL, BRENT",COLUMBIA UNIV NEW YORK MORNINGSIDE,NY,"$350,176"
Ovarian Cancer,2016,NIBIB,5R01EB019458-02,,Pre-clinical quantitation of ovarian cancer tumor burden using Magnetic Particle Imaging and non-dilutive cell labeling,"CONOLLY, STEVEN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$483,566"
Ovarian Cancer,2016,NCI,4F32CA177094-03,,Peptide-mediated delivery of siRNA for treatment of ovarian cancer,"KWON, ESTER",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$26,575"
Ovarian Cancer,2016,NCI,5R01CA184088-02,,Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy,"KABANOV, ALEXANDER",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$344,549"
Ovarian Cancer,2016,NIGMS,5R01GM113253-02,,Role of the checkpoint clamp in double-strand break repair,"KAI, MIHOKO",JOHNS HOPKINS UNIVERSITY,MD,"$311,850"
Ovarian Cancer,2016,NCI,5R01CA186700-02,,Study of biomarkers in ovarian cancer: modulation by activity & diet intervention,"THOMSON, CYNTHIA",UNIVERSITY OF ARIZONA,AZ,"$615,463"
Ovarian Cancer,2016,NCI,5R01CA190498-02,,gp130 as a novel therapeutic target in ovarian cancer,"NEAMATI, NOURI",UNIVERSITY OF MICHIGAN,MI,"$376,320"
Ovarian Cancer,2016,NCI,2U01CA152637-06,,"Breast, Colorectal, and Ovary Cancer Clinical Validation Center","LI, CHRISTOPHER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$1,011,430"
Ovarian Cancer,2016,NCI,1U01CA200469-01,,Development of in vitro diagnostic multivariate index assay using liquid-based cervical cytology specimen and/or serum/plasma biomarkers for the detection of early stage or low-volume ovarian cancer,"ZHANG, ZHEN",JOHNS HOPKINS UNIVERSITY,MD,"$463,212"
Ovarian Cancer,2016,NCI,2U01CA152990-06,,"Proteomic, Genomic, and Longitudinal Pathways to Ovarian Cancer Biomarker Discovery","SKATES, STEVEN",MASSACHUSETTS GENERAL HOSPITAL,MA,"$829,757"
Ovarian Cancer,2016,NCI,1U01CA200462-01,,MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer,"BAST, ROBERT",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$951,958"
Ovarian Cancer,2016,NCI,4R01CA163462-05,,MUC1 Roles in ovarian cancer pathogenesis and immune therapy,"VLAD, ANDA",MAGEE-WOMEN'S RES INST AND FOUNDATION,PA,"$287,489"
Ovarian Cancer,2016,NCI,4R01CA172743-04,,Impact of BRCA Testing on Newly Diagnosed U.S. Breast Cancer Patients,"SUTPHEN, REBECCA",UNIVERSITY OF SOUTH FLORIDA,FL,"$657,997"
Ovarian Cancer,2016,NCI,4R01CA174643-09,,The role of ERRalpha/PGC-1 in disease pathogenesis,"MCDONNELL, DONALD",DUKE UNIVERSITY,NC,"$314,209"
Ovarian Cancer,2016,NCI,4R01CA174470-25,,Stimulation of Tumorigenesis by NKG2D,"SPIES, THOMAS",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$581,772"
Ovarian Cancer,2016,NCI,4R01CA047135-26,,Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics,"CREWS, PHIL",UNIVERSITY OF CALIFORNIA SANTA CRUZ,CA,"$640,899"
Ovarian Cancer,2016,NCI,4UM1CA173642-04,,Women's Health Initiative Cancer Survivor Cohort,"ANDERSON, GARNET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$2,396,733"
Ovarian Cancer,2016,NCI,5P30CA015704-41,5446,Research Program: Women's Cancer,"PORTER, PEGGY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$69,377"
Ovarian Cancer,2016,NCI,5R01CA109298-12,,Ovarian Cancer: Mechanisms of Neuroendocrine Regulation,"SOOD, ANIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$356,980"
Ovarian Cancer,2016,NCI,1R01CA200854-01,,Characterizing Molecular Subtypes of Ovarian Cancer in African-American Women,"DOHERTY, JENNIFER",DARTMOUTH COLLEGE,NH,"$577,159"
Ovarian Cancer,2016,NCI,4R01CA163345-05,,Targeting Ovarian Tumor Associated Myeloid Cells with Nanoparticles Therapeutics,"BUCKANOVICH, RONALD",UNIVERSITY OF MICHIGAN,MI,"$322,663"
Ovarian Cancer,2016,NCI,1K07CA201013-01,,Health Services Career Development: Improving Medical Decisions in Ovarian Cancer,"MEYER, LARISSA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$170,506"
Ovarian Cancer,2016,NCI,1K08CA201544-01,,Tumor Genetics and Response to Checkpoint Blockade in Melanoma and Ovarian Cancer,"SNYDER CHAREN, ALEXANDRA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$180,036"
Ovarian Cancer,2016,NCI,5R01CA190176-02,,Effector T Cell Trafficking in Ovarian Cancer,"ZOU, WEIPING",UNIVERSITY OF MICHIGAN,MI,"$513,972"
Ovarian Cancer,2016,NCI,1R03CA194643-01A1,,Communicate and LEarn About youR Variant of Uncertain Significance (CLEAR VUS),"SCHERR, COURTNEY",NORTHWESTERN UNIVERSITY,IL,"$87,900"
Ovarian Cancer,2016,NCI,5R01CA190423-02,,Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer,"KAUFMANN, SCOTT",MAYO CLINIC ROCHESTER,MN,"$403,926"
Ovarian Cancer,2016,NCI,4R01CA168758-04,,Epidemiologic factors and survival by molecular subtypes of ovarian cancer,"ROSSING, MARY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$654,304"
Ovarian Cancer,2016,NCI,1R03CA191527-01A1,,Deletion of Arid1a and Kras as a Model of Endometriosis-Associated Ovarian Cancer,"HAWKINS, SHANNON",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$78,000"
Ovarian Cancer,2016,NCI,1R21CA194965-01A1,,Evolving Model of Cancer Susceptibility Testing: Clinical Decisions & Outcomes,"SCHWARTZ, MARC",GEORGETOWN UNIVERSITY,DC,"$202,928"
Ovarian Cancer,2016,NIGMS,5R01GM113940-02,,NIR-activatable Prodrugs for Treating Peritoneally Metastasized Ovarian Cancers,"YOU, YOUNGJAE",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$108,595"
Ovarian Cancer,2016,NCI,4R01CA169604-04,,Metabolic changes in ovarian cancer cells initiated by metastasis to adipose tiss,"LENGYEL, ERNST",UNIVERSITY OF CHICAGO,IL,"$327,850"
Ovarian Cancer,2016,NCI,1R21CA181994-01A1,,Targeted Molecular Imaging of Cell Death in Ovarian Cancer,"MILLWARD, STEVEN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$174,000"
Ovarian Cancer,2016,NCI,4R01CA169200-04,,The FGF18/FGFR4 amplicon: Novel therapeutic biomarkers for ovarian cancer,"BIRRER, MICHAEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$372,052"
Ovarian Cancer,2016,NCI,5R01CA181543-03,,Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells,"BRUGGE, JOAN",HARVARD MEDICAL SCHOOL,MA,"$396,541"
Ovarian Cancer,2016,NCI,5R01CA183040-03,,Ovarian cancer gene therapy using HPV pseudovirion,"WU, TZYY-CHOOU",JOHNS HOPKINS UNIVERSITY,MD,"$336,150"
Ovarian Cancer,2016,NCI,2R01CA136512-06A1,,BRCA1 Function in Post-Damage Nuclear Foci,"LIVINGSTON, DAVID",DANA-FARBER CANCER INST,MA,"$515,452"
Ovarian Cancer,2016,NCI,2R01CA119171-09A1,,Nutrition and Physical Activity Assessment Study (NPAAS),"NEUHOUSER, MARIAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$843,797"
Ovarian Cancer,2016,NCI,1R01CA193249-01A1,,Behavioral Influences on Ovarian Cancer Progression: Role of Chemoresistance,"LUTGENDORF, SUSAN",UNIVERSITY OF IOWA,IA,"$668,888"
Ovarian Cancer,2016,NCI,5R01CA115483-12,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$337,307"
Ovarian Cancer,2016,NCI,5R01CA142698-07,,Molecular mechanism and relevance of microRNAs in DSB repair pathway choice,"CHOWDHURY, DIPANJAN",DANA-FARBER CANCER INST,MA,"$409,002"
Ovarian Cancer,2016,NCI,1R01CA193511-01A1,,NOX4 mediates oxidative stress in ovarian tumor growth and treatment response,"JIANG, BINGHUA",THOMAS JEFFERSON UNIVERSITY,PA,"$356,850"
Ovarian Cancer,2016,NCI,1R01CA194064-01A1,,Combination Therapy of OvCa with Oligonucleotides and Photodynamic Therapy,"MING, XIN",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$84,166"
Ovarian Cancer,2016,NICHD,1R01HD083930-01A1,,Cryopreservation and Transplantation of Ovarian Cortical Tissue for Fertility Preservation,"ZELINSKI, MARY",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$605,663"
Ovarian Cancer,2016,NCI,2R01CA136494-07A1,,Molecular Mechanism of Antiangiogenic Properties of Gold Nanoparticle,"MUKHERJEE, PRIYABRATA",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$116,351"
Ovarian Cancer,2016,NCI,1R01CA202846-01,,Targeted therapy of peritoneal carcinomatosis using theranostic nanoparticles,"YANG, LILY",EMORY UNIVERSITY,GA,"$425,268"
Ovarian Cancer,2016,NCI,5P30CA010815-47,6194,Tumor Microenvironment and Metastasis,"ALTIERI, DARIO",WISTAR INSTITUTE,PA,"$31,844"
Ovarian Cancer,2016,NCI,1R01CA202919-01,,Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer,"ZHANG, RUGANG",WISTAR INSTITUTE,PA,"$434,625"
Ovarian Cancer,2016,NCI,1R01CA194498-01A1,,CDK12 in Ovarian Cancer,"KARNITZ, LARRY",MAYO CLINIC ROCHESTER,MN,"$383,982"
Ovarian Cancer,2016,NCI,5R21CA191690-02,,Identifying BRCA1 protein variants that provide resistance to therapy,"JOHNSON, NEIL",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$232,943"
Ovarian Cancer,2016,NCI,1R21CA191243-01A1,,Label-free microfluidic enrichment of cancer cells from noncancer cells in ascites fluid,"SULCHEK, TODD",GEORGIA INSTITUTE OF TECHNOLOGY,GA,"$222,446"
Ovarian Cancer,2016,NCI,5U10CA180860-03,,Integrated Translational Genoproteomics Center at Washington University,"MUTCH, DAVID",WASHINGTON UNIVERSITY,MO,"$428,007"
Ovarian Cancer,2016,NIGMS,5R01GM111093-03,,Glycosylation-dependent mechanisms regulating ovarian tumor cell survival,"BELLIS, SUSAN",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$279,300"
Ovarian Cancer,2016,NLM,5K01LM012100-02,,Informatic Methods for Differential Signaling and Immune Co-Regulatory Expression,"ENG, KEVIN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$166,879"
Ovarian Cancer,2016,NCI,5R01CA175318-02,,A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer,"HATEFI, ARASH","RUTGERS, THE STATE UNIV OF N.J.",NJ,"$354,563"
Ovarian Cancer,2016,NCI,5R01CA095175-12,,Analysis of BRCA1 Recombination Functions,"SCULLY, RALPH",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$328,700"
Ovarian Cancer,2016,NCI,4R01CA172272-04,,The BARD1 tumor suppressor and breast cancer,"BAER, RICHARD",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$332,000"
Ovarian Cancer,2016,NCI,5K99CA194309-02,,Nucleotide Metabolism in Senescence and Platinum Resistance of Ovarian Cancer,"AIRD, KATHERINE",WISTAR INSTITUTE,PA,"$115,014"
Ovarian Cancer,2016,NCI,1F31CA203039-01,,Design and synthesis of stabilized pironetin analogs for the treatment of resistant ovarian cancers,"COULUP, SARA",UNIVERSITY OF MINNESOTA,MN,"$29,327"
Ovarian Cancer,2016,NCI,1R44CA203350-01,,Genetic Cytology for Ovarian and Endometrial Cancer Screening,"KINDE, ISAAC","PAPGENE, INC.",MD,"$296,784"
Ovarian Cancer,2016,NCI,5R03CA184306-02,,Development of a Web-Based Group Intervention to Support Ovarian Cancer Survivors,"LUTGENDORF, SUSAN",UNIVERSITY OF IOWA,IA,"$79,565"
Ovarian Cancer,2016,NCI,1R01CA196631-01A1,,A network platform to connect drug response and prognosis phenotypes for cancers,"LI, HU",MAYO CLINIC ROCHESTER,MN,"$395,911"
Ovarian Cancer,2016,NCI,1F31CA203476-01,,A Multimodal Imaging Strategy for Preclinical Optimization of Anticancer Nanomedicines,"RADFORD, DAVID",UNIVERSITY OF UTAH,UT,"$34,274"
Ovarian Cancer,2016,NCI,1R01CA203348-01,,Blocking NK cell shedding of CD16a to increase cancer cell killing,"WALCHECK, BRUCE",UNIVERSITY OF MINNESOTA,MN,"$443,533"
Ovarian Cancer,2016,NCI,5R01CA138835-07,,The RAP80-BRCC36 Deubiquitinating Complex in DNA Repair,"GREENBERG, ROGER",UNIVERSITY OF PENNSYLVANIA,PA,"$317,509"
Ovarian Cancer,2016,NCI,4R01CA160669-05,,Mitochondrial DNA and Ovarian Cancer Risk and Survival,"COOK, LINDA",UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,"$318,673"
Ovarian Cancer,2016,NCI,4R01CA163377-05,,Role of EZH2 in Epithelial Ovarian Cancer,"ZHANG, RUGANG",WISTAR INSTITUTE,PA,"$354,825"
Ovarian Cancer,2016,NCI,5R01CA184502-03,,(PQD5) Avatar-directed Treatment for Ovarian Cancer,"WEROHA, SARAVUT",MAYO CLINIC ROCHESTER,MN,"$714,297"
Ovarian Cancer,2016,NIGMS,5SC1CA199810-02,,Novel Nanotechnology Platform for Breast Cancer Treatment,"AKALA, EMMANUEL",HOWARD UNIVERSITY,DC,"$377,500"
Ovarian Cancer,2016,NCI,4R01CA180769-08,,Signaling Connections Controlling Cell Motility and Invasion,"SCHLAEPFER, DAVID",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$376,500"
Ovarian Cancer,2016,NCI,4U01CA168409-05,,COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS,"POWERS, SCOTT",COLD SPRING HARBOR LABORATORY,NY,"$1,420,487"
Ovarian Cancer,2016,NCI,4U01CA176058-04,,The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center,"HAHN, WILLIAM",DANA-FARBER CANCER INST,MA,"$698,459"
Ovarian Cancer,2016,NCI,5R01CA184968-03,,(PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian Cancers,"SIKIC, BRANIMIR",STANFORD UNIVERSITY,CA,"$509,161"
Ovarian Cancer,2016,NCI,5R21CA194626-02,,(PQA3) Why is Ovarian Cancer Primarily a Disease of Postmenopausal Women,"ORSULIC, SANDRA",CEDARS-SINAI MEDICAL CENTER,CA,"$190,313"
Ovarian Cancer,2016,NCI,5R01CA176166-03,,Identifying Biomarkers of Cisplatin Resistance Mechanisms in Ovarian Cancer,"CANTOR, SHARON",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$347,563"
Ovarian Cancer,2016,NCI,4R01CA131407-09,,Re-activating Memory T Cells in the Microenvironment of Human Tumors,"BANKERT, RICHARD",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$326,400"
Ovarian Cancer,2016,NCI,7R01CA157481-05,,"Bmi-1, a potential therapeutic target in ovarian cancer","BHATTACHARYA, RESHAM",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$311,480"
Ovarian Cancer,2016,NICHD,4R01HD073499-04,,Genetic regulation of ovariole development in Drosophila,"EXTAVOUR, CASSANDRA",HARVARD UNIVERSITY,MA,"$413,174"
Ovarian Cancer,2016,NCI,4R01CA174904-04,,Roles of Chromatin Modification in BRCA1 Dependent DNA Repair,"GREENBERG, ROGER",UNIVERSITY OF PENNSYLVANIA,PA,"$332,000"
Ovarian Cancer,2016,NCI,5R21CA198409-02,,Targeting Ovarian Cancer Stem Cells Through Selective Inhibition of ALDH1A1,"HURLEY, THOMAS",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$169,467"
Ovarian Cancer,2016,NCI,5R01CA181258-03,,Chemically Programmed Bispecific Antibodies for Cancer Therapy,"RADER, CHRISTOPH",SCRIPPS FLORIDA,FL,"$398,400"
Ovarian Cancer,2016,NCI,5R01CA182413-02,,Origins of Ovarian Carcinoma,"NIKITIN, ALEXANDER",CORNELL UNIVERSITY,NY,"$358,780"
Ovarian Cancer,2016,NCI,5R01CA188900-02,,Novel immunological biomarkers ovarian cancer prognosis,"SEGAL, BRAHM",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$646,389"
Ovarian Cancer,2016,NCI,4U01CA176270-04,,Profiling cancer neoantigen repertoires and validating immunotherapy targets,"MCINTOSH, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$1,064,486"
Ovarian Cancer,2016,NCI,5R01CA195670-02,,The Tumor Suppressor Role of SMARCA4 in SCCOHT,"WEISSMAN, BERNARD",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$781,296"
Ovarian Cancer,2016,NCI,5R01CA197359-02,,Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy,"BERLIN, JACOB",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$388,875"
Ovarian Cancer,2016,NCI,4R01CA175480-04,,Tumor-targeted Polymersomes to image and Treat Ovarian Cancer,"CHENG, ZHILIANG",UNIVERSITY OF PENNSYLVANIA,PA,"$327,652"
Ovarian Cancer,2016,NCI,5R01CA176078-03,,Dissecting the role of STAT3 and targeting ovarian cancer,"KARUPPAIYAH, SELVENDIRAN",OHIO STATE UNIVERSITY,OH,"$320,524"
Ovarian Cancer,2016,NIGMS,1R35GM118175-01,,Homologous recombination mechanisms in mammalian cells,"JASIN, MARIA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$293,822"
Ovarian Cancer,2016,NCI,1R01CA203971-01,,Deubiquitinases in regulation of BRCA1 pathway,"YUAN, JIAN",MAYO CLINIC ROCHESTER,MN,"$363,713"
Ovarian Cancer,2016,NCI,4P01CA066726-19,5805,Clinical Trials in Mesothelioma,"STERMAN, DANIEL",UNIVERSITY OF PENNSYLVANIA,PA,"$302,808"
Ovarian Cancer,2016,NCI,5R01CA132755-09,,Molecular Mechanisms of BRCA1-Dependent DNA Damage Response and Tumorogenesis,"YU, XIAOCHUN",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$382,500"
Ovarian Cancer,2016,NCI,4R01CA177909-04,,Platelets promote growth of ovarian cancer,"AFSHAR-KHARGHAN, VAHID",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$332,000"
Ovarian Cancer,2016,NCI,1R01CA204119-01,,Early Detection of Ovarian Cancer Through Epigenetic Factors in the WHI,"GENKINGER, JEANINE",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$401,317"
Ovarian Cancer,2016,NCI,5F32CA196008-02,,Elucidation of the impact of commonly co-altered genes on chemosensitivity using a novel model of high-grade serous ovarian cancer,"CHEN, HSING-YU",HARVARD MEDICAL SCHOOL,MA,"$58,002"
Ovarian Cancer,2016,NCI,4R01CA178687-04,,Effects of common polymorphisms in immune sensors in tumor immunosurveillance,"CONEJO-GARCIA, JOSE",WISTAR INSTITUTE,PA,"$387,166"
Ovarian Cancer,2016,NIBIB,4R01EB016582-04,,Tissue-dynamics Imaging for Therapeutic Efficacy in Ovarian Cancer,"NOLTE, DAVID",PURDUE UNIVERSITY,IN,"$330,976"
Ovarian Cancer,2016,NCI,7R01CA172404-04,,Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer,"RAMUS, SUSAN",UNIVERSITY OF NEW SOUTH WALES,AUSTRA,"$491,893"
Ovarian Cancer,2016,NCI,4P30CA046592-28,6455,Cancer Genetics,"WICHA, MAX",UNIVERSITY OF MICHIGAN,MI,"$241,479"
Ovarian Cancer,2016,NCI,4R01CA121113-10,,Large-scale Genetic Analyses of Human Cancer,"VELCULESCU, VICTOR",JOHNS HOPKINS UNIVERSITY,MD,"$279,212"
Ovarian Cancer,2016,NCI,5R01CA188251-03,,Molecular Insights into the Fanconi Anemia Tumor Suppressor Signaling Pathway,"FEI, PEIWEN",UNIVERSITY OF HAWAII AT MANOA,HI,"$319,550"
Ovarian Cancer,2016,NCI,5U01CA181628-03,,Novel Activatable Fluorophores for Multicolor Fluorescence-Guided Cancer Surgery,"PTASZEK, MARCIN",UNIVERSITY OF MARYLAND BALT CO CAMPUS,MD,"$196,403"
Ovarian Cancer,2016,NCI,1R03CA191543-01A1,,Enhancing at-Risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer,"HURTADO DE MENDOZA CASAUS, ALEJANDRA",GEORGETOWN UNIVERSITY,DC,"$79,305"
Ovarian Cancer,2016,NCI,4R01CA164122-05,,B7-H1 Signaling in Ovarian Cancer,"CURIEL, TYLER",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$310,213"
Ovarian Cancer,2016,NCI,4R01CA164729-05,,"Integrative Cancer Genomics: Drivers, Pathways and Drugs","PE'ER, DANA",COLUMBIA UNIV NEW YORK MORNINGSIDE,NY,"$464,984"
Ovarian Cancer,2016,NCI,7R01CA196200-02,,Ovarian Cancer Chemoprevention,"BENBROOK, DORIS",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$503,992"
Ovarian Cancer,2016,NCI,5R01CA131582-07,,Identification of Ovarian Cancer Plasma Biomarkers,"SPEICHER, DAVID",WISTAR INSTITUTE,PA,"$452,569"
Ovarian Cancer,2016,NCI,5R01CA188571-02,,"DYRK1A signaling in control of cell growth, proliferation and DNA damage repair","LITOVCHICK, LARISA",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$341,494"
Ovarian Cancer,2016,NCI,4R01CA166907-04,,Transplatin: A Novel Agent to Mitigate Cisplatin Toxicity,"RAMKUMAR, VICKRAM",SOUTHERN ILLINOIS UNIVERSITY SCH OF MED,IL,"$302,080"
Ovarian Cancer,2016,NCI,4R01CA124515-11,,Vascular Leukocytes Influence the Tumor Microenvironment,"CONEJO-GARCIA, JOSE",WISTAR INSTITUTE,PA,"$350,170"
Ovarian Cancer,2016,NIGMS,1R15GM119116-01,,New Photostable Nanoprobes for Real-time Imaging of Single Live Cells,"XU, X. NANCY",OLD DOMINION UNIVERSITY,VA,"$465,000"
Ovarian Cancer,2016,NCI,1R21CA205322-01,,Multiplexed exosome analyses with DNA barcoding,"LEE, HAKHO",MASSACHUSETTS GENERAL HOSPITAL,MA,"$239,828"
Ovarian Cancer,2016,NCI,1R21CA198263-01A1,,Cbx-3/HP-1gamma deficiency confers anti-tumor immunity,"THAI, TO-HA",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$188,138"
Ovarian Cancer,2016,NCI,1R21CA205819-01,,Modeling the impact of mutations in ubiquitin ligase genes on transcriptional programs in endometrial cancer,"LESLIE, CHRISTINA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$223,677"
Ovarian Cancer,2016,NCI,4U01CA168870-05,,Glycomics Laboratory for the Early Detection of Epithelial Ovarian Cancer,"ABBOTT, KAREN",UNIV OF ARKANSAS FOR MED SCIS,AR,"$360,837"
Ovarian Cancer,2016,NCI,1R01CA196619-01A1,,Credentialing Ovarian Cancer Models in the Context of the Dualistic Pathway Paradigm,"CHO, KATHLEEN",UNIVERSITY OF MICHIGAN,MI,"$471,755"
Ovarian Cancer,2016,NCCIH,1R01AT008824-01A1,,Botanical derived progestins and their impact on women's health,"BURDETTE, JOANNA",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$359,775"
Ovarian Cancer,2016,NIMHD,1R01MD009697-01A1,,Spatiotemporal Analysis of Disparities in Ovarian Cancer Treatment and Survival,"BRISTOW, ROBERT",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$386,250"
Ovarian Cancer,2016,NCI,5R01CA199004-02,,Targeting the vascularity for delivery of inhibitors of metastasis in ovarian cancer,"MOR, GIL",YALE UNIVERSITY,CT,"$511,177"
Ovarian Cancer,2016,NCI,1R01CA197780-01A1,,Examining the role of the miR-181a:Wnt/B-catenin axis in ovarian cancer,"DIFEO, ANALISA",CASE WESTERN RESERVE UNIVERSITY,OH,"$376,963"
Ovarian Cancer,2016,NCI,1R01CA193965-01A1,,Redefining Normal: personalized CA125 cutpoints for ovarian cancer screening,"TERRY, KATHRYN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$438,367"
Ovarian Cancer,2016,NCI,1R01CA197784-01A1,,Comparison of 3 Modes of Genetic Counseling in High-Risk Public Hospital Patients,"PASICK, RENA","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$652,127"
Ovarian Cancer,2016,NCI,1R01CA200231-01A1,,PHARMACOLOGICAL MODULATION OF POLY(ADP-RIBOSE) METABOLISM,"ELLENBERGER, TOM",WASHINGTON UNIVERSITY,MO,"$38,898"
Ovarian Cancer,2016,NCI,1R01CA197976-01A1,,The Hippo/YAP Signaling Pathway in Ovarian High Grade Serous Carcinoma,"WANG, CHENG",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$344,269"
Ovarian Cancer,2016,NCI,5R21CA191725-02,,4C and Genome Editing for Causal SNP and Gene Discovery at Cancer Risk Loci,"FREEDMAN, MATTHEW",DANA-FARBER CANCER INST,MA,"$185,077"
Ovarian Cancer,2016,NCI,5R21CA187289-02,,Mitochondrially Targeted p53 DBD for Treatment of Ovarian Cancer,"LIM, CAROL",UNIVERSITY OF UTAH,UT,"$194,445"
Ovarian Cancer,2016,NCI,5R01CA193578-02,,Tunable Microchip Sorting of BRCA1 Nuclear Assemblies,"KELLY, DEBORAH",VIRGINIA POLYTECHNIC INST AND ST UNIV,VA,"$358,743"
Ovarian Cancer,2016,NCI,5F30CA192648-02,,Deciphering Links Between Inflammation and Cancer with IMP-1 Inhibitors,"MAHAPATRA, LILY",UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN,IL,"$48,576"
Ovarian Cancer,2016,NCI,1K99CA197487-01A1,,Role of DEAD-box helicase in microRNA biogenesis and Cancer,"HAN, CECIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$101,631"
Ovarian Cancer,2016,NCI,5R21CA198795-02,,PET Kinetic Modeling of Inhibiting Glycolysis in Ovarian Cancer,"AVRIL, NORBERT",CASE WESTERN RESERVE UNIVERSITY,OH,"$222,296"
Ovarian Cancer,2016,NCI,5R01CA193136-02,,MDSCs in Ovarian Cancer,"ZOU, WEIPING",UNIVERSITY OF MICHIGAN,MI,"$498,257"
Ovarian Cancer,2016,NINR,5F31NR015170-02,,Hormone Therapy Decision Making in Older Women,"HUNTER, MARY","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$35,027"
Ovarian Cancer,2016,NCI,5R01CA102310-13,,Role of FAK in Tumorigenesis,"SCHLAEPFER, DAVID",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$331,313"
Ovarian Cancer,2016,NCI,5R01CA135354-06,,ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer,"BAST, ROBERT",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$380,000"
Ovarian Cancer,2016,NCI,5F30CA183395-03,,Control of the apoptosome in epithelial ovarian cancer to enhance chemotherapy,"COCCE, KIMBERLY",DUKE UNIVERSITY,NC,"$33,987"
Ovarian Cancer,2016,NIAID,4K06AI004739-55,,BIOCHEMISTRY OF VIRAL REPLICATION,"GREEN, MAURICE",SAINT LOUIS UNIVERSITY,MO,"$33,939"
Ovarian Cancer,2016,NCI,4R01CA111882-10,,Regulation of Adhesion and Proteolysis in Ovarian Cancer,"LENGYEL, ERNST",UNIVERSITY OF CHICAGO,IL,"$272,318"
Ovarian Cancer,2016,NCI,4P50CA159981-04,5590,"Inhibition of indole-amine 2,3 dioxygenase to Enhance Ovarian Tumor Immunity","ODUNSI, KUNLE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$109,724"
Ovarian Cancer,2016,NCI,4P50CA159981-04,5591,Rapamycin and IL-21 Conditioned CD8+ T Cells for Adoptive Cellular Therapy of Ov,"SHRIKANT, PROTUL",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$144,478"
Ovarian Cancer,2016,NCI,4P50CA159981-04,5593,MHC-Restricted and MHC-Non-Restricted Targeting of Ovarian Cancer by alphaDC1,"KALINSKI, PAWEL",UNIVERSITY OF PITTSBURGH,PA,"$149,868"
Ovarian Cancer,2016,NCI,4P50CA159981-04,5595,Administrative Core,"ODUNSI, KUNLE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$1,278"
Ovarian Cancer,2016,NCI,4P50CA159981-04,5596,Biospecimen Core,"MORRISON, CARL",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$1,282"
Ovarian Cancer,2016,NCI,4P50CA159981-04,5597,Biostatistics/Medical Informatics,"HUTSON, ALAN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$1,402"
Ovarian Cancer,2016,NCI,4P50CA159981-04,5598,Immune Monitoring Core,"WALLACE, PAUL",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$1,068"
Ovarian Cancer,2016,NCI,4P50CA159981-04,5599,Developmental Research Program,"MOYSICH, KIRSTEN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$1,320"
Ovarian Cancer,2016,NCI,4P50CA159981-04,5600,Career Development Program,"LELE, SHASHIKANT",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$1,373"
Ovarian Cancer,2016,NCI,5R21CA186846-03,,Integrated Microfluidic Exosome Profiling for Early Detection of Cancer,"ZENG, YONG",UNIVERSITY OF KANSAS LAWRENCE,KS,"$212,274"
Ovarian Cancer,2016,NCI,5R01CA190237-02,,Targeting BRCA Deficient Cells for Killing,"POMERANTZ, RICHARD",TEMPLE UNIV OF THE COMMONWEALTH,PA,"$356,850"
Ovarian Cancer,2016,NCI,5P30CA047904-28,6388,Cancer Epidemiology and Prevention Program (Project-005),"YUAN, JIAN-MIN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$35,976"
Ovarian Cancer,2016,NCI,5P30CA047904-28,6390,Breast and Ovarian Cancer Program (Project-007),"LEE, ADRIAN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$34,673"
Ovarian Cancer,2016,NCI,1R01CA206561-01,,Quantitative assessment of the role of collagen alterations in ovarian cancer,"CAMPAGNOLA, PAUL",UNIVERSITY OF WISCONSIN-MADISON,WI,"$387,549"
Ovarian Cancer,2016,NCI,5F31CA186376-02,,Role of estrogen receptor-alpha in ovarian cancer,"ANDERSEN, COURTNEY",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$8,586"
Ovarian Cancer,2016,NCI,5R21CA197225-02,,Generation and characterization of adduct-specific anti cisplatin DNA antibodies,"SCHARER, ORLANDO",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$170,210"
Ovarian Cancer,2016,NCI,5R01CA188943-02,,Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors,"HILDEBRANDT, MICHELLE",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$1,200,669"
Ovarian Cancer,2016,NCI,4R01CA180710-04,,Targeting nucleotide excision repair in combination cancer therapy,"TURCHI, JOHN",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$323,700"
Ovarian Cancer,2016,NCI,5R01CA188025-03,,Iron addiction and the biology of ovarian cancer,"TORTI, SUZY",UNIVERSITY OF CONNECTICUT SCH OF MED/DNT,CT,"$386,630"
Ovarian Cancer,2016,NCI,4U01CA116167-09,,BRCA1 and BRCA2 missense mutations and breast cancer risk,"COUCH, FERGUS",MAYO CLINIC ROCHESTER,MN,"$527,128"
Ovarian Cancer,2016,NCI,4K07CA166210-04,,Chemotherapy Near Death: Modifiable Factors and Outcomes in Ovarian Cancer,"WRIGHT, ALEXI",DANA-FARBER CANCER INST,MA,"$177,120"
Ovarian Cancer,2016,NCI,5R00CA184043-04,,Targeting Ovarian Cancer via Cooperative Oncogene Interactions,"HARGREAVES, DIANA",SALK INSTITUTE FOR BIOLOGICAL STUDIES,CA,"$249,000"
Ovarian Cancer,2016,NCI,5R01CA181808-03,,Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis,"RICHARDS, JOANNE",BAYLOR COLLEGE OF MEDICINE,TX,"$356,313"
Ovarian Cancer,2016,NCI,5R35CA197458-02,,GENOMIC ANALYSIS OF INHERITED BREAST AND OVARIAN CANCER,"KING, MARY-CLAIRE",UNIVERSITY OF WASHINGTON,WA,"$899,750"
Ovarian Cancer,2016,NCI,4K01CA172591-05,,"EGF receptor, DNA methylation and platinum resistance in ovarian cancer","SAMUDIO-RUIZ, SABRINA",UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,"$129,216"
Ovarian Cancer,2016,NCI,5UM1CA182910-04,,Shanghai Womens Health Study,"ZHENG, WEI",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$624,799"
Ovarian Cancer,2016,RMAP,5UH3TR000943-04,,Novel extra cellular RNA-based combinatorial RNA inhibition therapy,"SOOD, ANIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$1,000,000"
Ovarian Cancer,2016,NCI,4F31CA174316-05,,Structural mutation analysis of PTEN and its possible genotype-phenotype correlat,"SMITH, IRIS",UNIVERSITY OF HOUSTON,TX,"$29,078"
Ovarian Cancer,2016,NCI,4U54CA163071-05,7991,Identifying Cancer Health Communication Channels for Hispanic Audiences,"JIMENEZ, JUILO",PONCE SCHOOL OF MEDICINE,PR,"$88,410"
Ovarian Cancer,2016,NCI,5R01CA187209-03,,Functional analysis of BRCA1 in DNA damage response and tumor suppression,"YU, XIAOCHUN",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$352,750"
Ovarian Cancer,2016,NCI,5R21CA190930-02,,Subharmonic Contrast Ultrasound for Improved Characterization of Adnexal Masses,"FORSBERG, FLEMMING",THOMAS JEFFERSON UNIVERSITY,PA,"$169,650"
Ovarian Cancer,2016,NCI,5F31CA192891-03,,Evaluating Notch Signaling as a Therapeutic Target in Ovarian Cancer,"PRICE, JESSICA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$44,343"
Ovarian Cancer,2016,NCI,5K99CA194318-02,,Targeting Wnt signaling to overcome PARP inhibitor resistance in ovarian cancer,"BITLER, BENJAMIN",WISTAR INSTITUTE,PA,"$115,014"
Ovarian Cancer,2016,NCI,5R03CA198822-02,,Scutellaria Baicalensis Targets HIF-1(alpha) in Cancer,"SYED, VIQAR",HENRY M. JACKSON FDN FOR THE ADV MIL/MED,MD,"$77,878"
Ovarian Cancer,2016,NCI,5F31CA186625-03,,Refining ovarian cancer subtype classifiers to incorporate biologic features,"RUDD, JAMES",DARTMOUTH COLLEGE,NH,"$43,576"
Ovarian Cancer,2016,NCI,5R01CA195723-02,,Validating a mouse model of ovarian cancer for early detection through imaging,"BARTON, JENNIFER",UNIVERSITY OF ARIZONA,AZ,"$570,435"
Ovarian Cancer,2016,NCI,1R44CA206606-01,,A Phase I Dose-escalation Study of Intraperitoneal CYN101 as Consolidation Immunotherapy in Women with Residual or Recurrent Ovarian Cancer Status after Chemotherapy,"WILDS, DAN","CYNVEC, LLC",NY,"$995,814"
Ovarian Cancer,2016,NCI,1R43CA195841-01A1,,Isothermal Chain Reaction (ICR) Detection of SNP Biomarkers for Ovarian Cancer Pont-of-Care Testing and Risk Stratification,"MANCEBO, RICARDO","GENENDEAVOR, LLC",CA,"$299,998"
Ovarian Cancer,2016,NIGMS,1R35GM119512-01,,Connecting BRCA1 functions with DNA crosslink sensitivity,"LONG, DAVID",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$290,751"
Ovarian Cancer,2016,NCI,5R21CA187309-02,,Ashwagandha supplementation enhances ovarian tumoricidal activity of NK cells,"BARUA, ANIMESH",RUSH UNIVERSITY MEDICAL CENTER,IL,"$171,399"
Ovarian Cancer,2016,NCI,5R00CA166228-04,,A Pathway-based approach to investigate oncogenic mechanisms in ovarian cancer,"GATZA, MICHAEL",RBHS -CANCER INSTITUTE OF NEW JERSEY,NJ,"$249,000"
Ovarian Cancer,2016,NCI,5R01CA184717-03,,The Regulation of Cisplatin resistance in ovarian cancer,"ZHU, WENGE",GEORGE WASHINGTON UNIVERSITY,DC,"$328,888"
Ovarian Cancer,2016,NCI,5K08CA151892-06,,Targeting SRC Signaling Pathways to Promote Cell Cycle Arrest in Ovarian Cancer,"SIMPKINS, FIONA",UNIVERSITY OF PENNSYLVANIA,PA,"$130,770"
Ovarian Cancer,2016,NCI,5U01CA184910-03,,Validation of findings from the Epigenome-Wide Association Study of Breast Cancer,"STURGEON, SUSAN",UNIVERSITY OF MASSACHUSETTS AMHERST,MA,"$181,456"
Ovarian Cancer,2016,NCI,5R00CA184415-03,,Functional Analysis of LncRNAs in Epithelial Ovarian Cancer,"LAWRENSON, KATE",CEDARS-SINAI MEDICAL CENTER,CA,"$243,541"
Ovarian Cancer,2016,NCI,5K22CA181550-02,,Targeting defective DNA repair for the prevention of BRCA1-associated cancers,"ALLI, ELIZABETH",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$162,000"
Ovarian Cancer,2016,NIBIB,5R43EB021212-02,,CTC Screening Assay to Address Health Disparities in Women with Ovarian Cancer,"HUPERT, MATEUSZ","BIOFLUIDICA, INC",NC,"$199,833"
Ovarian Cancer,2016,NCI,2P50CA116201-11,8257,01 Project 1:  Cancer risks for mutations in breast cancer predisposition genes,"COUCH, FERGUS",MAYO CLINIC ROCHESTER,MN,"$478,350"
Ovarian Cancer,2016,NIGMS,5R01GM116829-02,,Structural basis of RNF168-mediated ubiquitin signaling at chromosomal DNA breaks,"MER, GEORGES",MAYO CLINIC ROCHESTER,MN,"$314,025"
Ovarian Cancer,2016,NCI,5K22CA181611-02,,Online monitoring and image-guided treatment of chemoresistant micrometastases,"SPRING, BRYAN",NORTHEASTERN UNIVERSITY,MA,"$186,396"
Ovarian Cancer,2016,NCI,5SC2CA206194-02,,Theranostic nanoparticles for dual modality cancer therapy,"CZAJKOWSKA, ANETA",BROOKLYN COLLEGE,NY,"$157,000"
Ovarian Cancer,2016,NCI,5P50CA136393-07,7019,Biospecimens and Patient Registry,"KEENEY, GARY",MAYO CLINIC ROCHESTER,MN,"$123,697"
Ovarian Cancer,2016,NCI,5P50CA136393-07,7020,Core C - Biostatistics Core,"OBERG, ANN",MAYO CLINIC ROCHESTER,MN,"$150,745"
Ovarian Cancer,2016,NCI,5P50CA136393-07,7021,Core D - Animal Models Core,"HALUSKA, PAUL",MAYO CLINIC ROCHESTER,MN,"$138,765"
Ovarian Cancer,2016,NCI,5P50CA136393-07,7022,Administrative Core,"KAUFMANN, SCOTT",MAYO CLINIC ROCHESTER,MN,"$527,228"
Ovarian Cancer,2016,NCI,5P50CA136393-07,7023,Project 1 - PARP Project,"KAUFMANN, SCOTT",MAYO CLINIC ROCHESTER,MN,"$187,355"
Ovarian Cancer,2016,NCI,5P50CA136393-07,7024,Project 6 - PKC Iota,"FIELDS, ALAN",MAYO CLINIC ROCHESTER,MN,"$272,554"
Ovarian Cancer,2016,NCI,5P50CA136393-07,7025,Project 7 - Metformin,"LENGYEL, ERNST",MAYO CLINIC ROCHESTER,MN,"$338,318"
Ovarian Cancer,2016,NCI,5P50CA136393-07,7026,Project 8 - TH17 Dendritic Cell Vaccine,"KNUTSON, KEITH",MAYO CLINIC ROCHESTER,MN,"$280,591"
Ovarian Cancer,2016,NCI,5P50CA136393-07,7027,Developmental Reserach Pilot Projects,"CLIBY, WILLIAM",MAYO CLINIC ROCHESTER,MN,"$95,166"
Ovarian Cancer,2016,NCI,5P50CA136393-07,7028,Career Development,"GOODE, ELLEN",MAYO CLINIC ROCHESTER,MN,"$47,581"
Ovarian Cancer,2016,NCI,5P01CA087969-17,8092,Core A: Biospecimen and High-Dimensional Data Management Core,"TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$629,635"
Ovarian Cancer,2016,NCI,5P01CA087969-17,8096,Project 3: Ovarian Cancer,"TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$240,294"
Ovarian Cancer,2016,NCI,5P01CA087969-17,8097,Project 4: Statistical Innovations,"ROSNER, BERNARD",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$168,164"
Ovarian Cancer,2016,NCI,5R01CA142746-07,,Enzyme-instructed self-assembly for molecular anticancer nanomedicines,"XU, BING",BRANDEIS UNIVERSITY,MA,"$368,145"
Ovarian Cancer,2016,NCI,2P30CA036727-30,5725,Molecular and Biochemical Etiology (MBE),"BAND, HAMID",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$57,053"
Ovarian Cancer,2016,NCI,1R01CA207034-01,,Mechanism of evasion by ovarian cancers from anti-VEGF therapy,"NAORA, HONAMI",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$366,000"
Ovarian Cancer,2016,NCI,1R01CA207497-01,,Provectors for treatment of ovarian cancer,"SUH, JUNGHAE",RICE UNIVERSITY,TX,"$365,548"
Ovarian Cancer,2016,NCI,1R01CA207456-01,,Epidemiology and biology of lncRNAs in ovarian cancer,"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$991,197"
Ovarian Cancer,2016,NCI,5P01CA190174-02,7470,Adminstrative Core,"SPRIGGS, DAVID",SLOAN-KETTERING INST CAN RESEARCH,NY,"$81,926"
Ovarian Cancer,2016,NCI,5P01CA190174-02,7471,Biostatistics Core,"IASONOS, ALEXIA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$79,911"
Ovarian Cancer,2016,NCI,5P01CA190174-02,7472,Pathology Core,"DELAIR, DEBORAH",SLOAN-KETTERING INST CAN RESEARCH,NY,"$81,925"
Ovarian Cancer,2016,NCI,5P01CA190174-02,7473,MUC16 Antibody Based Strategies for Imaging and Therapy,"SPRIGGS, DAVID",SLOAN-KETTERING INST CAN RESEARCH,NY,"$573,457"
Ovarian Cancer,2016,NCI,5P01CA190174-02,7474,Personalized Immunotherapy of Patients with Ovarian Cancer,"SABBATINI, PAUL",SLOAN-KETTERING INST CAN RESEARCH,NY,"$491,531"
Ovarian Cancer,2016,NCI,5P01CA190174-02,7475,Adoptive Therapy of Ovarian Cancer with Autologous Genetically Modified T Cells,"BRENTJENS, RENIER",SLOAN-KETTERING INST CAN RESEARCH,NY,"$409,610"
Ovarian Cancer,2016,NCI,5P01CA190174-02,7476,Enhanced Efficacy of MUC16 directed antibodies through modification of the Fc domain,"RAVETCH, JEFFREY",SLOAN-KETTERING INST CAN RESEARCH,NY,"$315,472"
Ovarian Cancer,2016,RMAP,1R21CA207816-01,,Integrated Digital Microfluidic Platforms for Next-Generation Glycomics,"ZENG, YONG",UNIVERSITY OF KANSAS LAWRENCE,KS,"$292,762"
Ovarian Cancer,2016,NCI,3U01CA168409-04S1,,COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS,"POWERS, SCOTT",COLD SPRING HARBOR LABORATORY,NY,"$70,071"
Ovarian Cancer,2016,NCI,1R15CA202775-01A1,,Targeting IKK and HDAC Mediated IL-8 Expression in Ovarian and Prostate Cancer,"VANCUROVA, IVANA",ST. JOHN'S UNIVERSITY,NY,"$495,000"
Ovarian Cancer,2016,NCI,2R01CA157664-06,,Initiation and Evolution of the Ovarian cancer Microenvironment,"CONEJO-GARCIA, JOSE",WISTAR INSTITUTE,PA,"$451,250"
Ovarian Cancer,2016,NCI,1R21CA208610-01,,Pax2 loss in fallopian tube lesions and strategies for restoration in serous cancer,"BURDETTE, JOANNA",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$196,475"
Ovarian Cancer,2016,NCI,1R01CA208753-01,,Cancer-Associated Fibroblasts Alter the Composition of B cells in Solid Malignancies,"ORSULIC, SANDRA",CEDARS-SINAI MEDICAL CENTER,CA,"$400,313"
Ovarian Cancer,2016,NCI,1R21CA202745-01A1,,Dim light at night alters pancreatic cell signaling and predisposes to pancreatic adenocarcinoma,"NELSON, RANDY",OHIO STATE UNIVERSITY,OH,"$200,970"
Ovarian Cancer,2016,NIGMS,2R01GM059078-17,,Molecular Probes for Biomembrane Recognition,"SMITH, BRADLEY",UNIVERSITY OF NOTRE DAME,IN,"$413,571"
Ovarian Cancer,2016,NCI,2R01CA155025-06A1,,The role of a BRCA1 associated complex in DNA damage response and tumor suppression,"WANG, BIN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$380,000"
Ovarian Cancer,2016,NCI,1R01CA181663-01A1,,Mechanisms of radioresistance and strategies for radiosensitization in OCCC,"PENG, GUANG",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$377,816"
Ovarian Cancer,2016,NIBIB,1R01EB020605-01A1,,Advanced Salpingoscope for Minimally-Invasive Imaging of the Fallopian Tubes,"BARTON, JENNIFER",UNIVERSITY OF ARIZONA,AZ,"$329,928"
Ovarian Cancer,2016,NCI,1R43CA203647-01A1,,Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer  Assays,"LIM, MARK","AMBERGEN, INC",MA,"$225,000"
Ovarian Cancer,2016,NCI,1R21CA209281-01,,Development of DNA Polymerase θ Inhibitors for Precision Medicine in BRCA Deficient Cancers,"POMERANTZ, RICHARD",TEMPLE UNIV OF THE COMMONWEALTH,PA,"$201,144"
Ovarian Cancer,2016,NCI,4R00CA179137-03,,"Understanding the origin,initiation,and progression of high-grade serous ovarian cancer","KIM, JAEYEON",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$248,999"
Ovarian Cancer,2016,NCI,1R21CA209848-01,,Algorithms for Literature-Guided Multi-Platform Identification of Cancer Subtypes,"CHUNG, DONGJUN",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$195,098"
Ovarian Cancer,2016,NCI,1U24CA209999-01,,Monitoring tumor subclonal heterogeneity over time and space,"MARTH, GABOR",UNIVERSITY OF UTAH,UT,"$748,920"
Ovarian Cancer,2016,NCI,1F30CA203095-01A1,,Transcriptomic profiling and functional characterization of fusion genes in recurrent ovarian cancer,"PRIEDIGKEIT, NOLAN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$48,576"
Ovarian Cancer,2016,NCI,1F32CA200357-01A1,,Role of Follicular Fluid Exosomes on Ovarian/Fallopian Carcinogenesis,"BRACHOVA, PAVLA",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$58,453"
Ovarian Cancer,2016,NCI,1R01CA210370-01,,Early detection of ovarian cancer by serum marker and targeted ultrasound imaging,"BARUA, ANIMESH",RUSH UNIVERSITY MEDICAL CENTER,IL,"$369,877"
Ovarian Cancer,2016,NCI,1R43CA206607-01A1,,JOC-x: Chemotherapy conjugates that open tumor tight junctions to treat cancer,"CARTER, DARRICK","PAI LIFE SCIENCES, INC.",WA,"$199,997"
Ovarian Cancer,2016,NIGMS,1R44GM121096-01,,"Novel enzymatic site-specific antibody drug conjugation technique to produce homogeneous antibody drug conjugate (ADC)s with improved safety, stability and efficacy","HU, SEAN","DOPHEN BIOMED, INC.",CA,"$149,625"
Ovarian Cancer,2016,NCI,261200800001E-96-0-36,,Repository Services for epidemiology studies,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$1,886,169"
Ovarian Cancer,2016,NCI,261200800001E-96-0-102,,Biospecimen Collection Proteomic,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$4,644,786"
Ovarian Cancer,2016,NCI,3UM1CA173642-04S1,,Women's Health Initiative Cancer Survivor Cohort,"ANDERSON, GARNET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$170,764"
Ovarian Cancer,2016,NCATS,1R21TR001731-01,,Ketorolac and Related NSAIDs for Targeting Rho-family GTPases in Ovarian Cancer,"WANDINGER-NESS, ANGELA",UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,"$303,000"
Ovarian Cancer,2016,NCI,1U24CA210954-01,,"iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC","ZHANG, BING",BAYLOR COLLEGE OF MEDICINE,TX,"$1,004,827"
Ovarian Cancer,2016,NCI,1U24CA210955-01,,PNNL Proteome Characterization Center,"LIU, TAO",BATTELLE PACIFIC NORTHWEST LABORATORIES,WA,"$1,123,778"
Ovarian Cancer,2016,NCI,7R01CA182832-03,,An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer,"MATEI, DANIELA",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$323,701"
Ovarian Cancer,2016,NCI,2U54CA163072-07,6543,Roles of proinflammatory chemokines linking obesity and ovarian cancer,"BEEGHLY-FADIEL, ALICIA",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$28,372"
Ovarian Cancer,2016,NCI,2U54CA163066-06,6613,Roles of proinflammatory chemokines linking obesity and ovarian cancer,"WHALEN, MARGARET",TENNESSEE STATE UNIVERSITY,TN,"$17,040"
Ovarian Cancer,2016,NCI,2U54CA163069-06,6965,Roles of proinflammatory chemokines linking obesity and ovarian cancer,"SON, DEOK-SOO",MEHARRY MEDICAL COLLEGE,TN,"$72,817"
Ovarian Cancer,2016,NCI,1K08CA211362-01,,Defining the formation and function of carcinoma-associated mesenchymal stem cells in the ovarian cancer microenvironment,"COFFMAN, LAN",UNIVERSITY OF MICHIGAN,MI,"$165,354"
Ovarian Cancer,2016,NCI,1R50CA211280-01,,Discovery and Characterization of Mutations in Breast and Ovarian Cancers,"ADAMSON, AARON",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$215,047"
Ovarian Cancer,2016,RMAP,3R01CA111882-10S1,,Regulation of Adhesion and Proteolysis in Ovarian Cancer,"LENGYEL, ERNST",UNIVERSITY OF CHICAGO,IL,"$171,564"
Ovarian Cancer,2016,NCI,1F99CA212222-01,,Inflammation and gynecologic cancer: the role of prostaglandins in ovarian cancer,"BARNARD, MOLLIE",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$32,292"
Ovarian Cancer,2016,NCI,1F99CA212460-01,,Identifying epigenetic drivers and their targets in aggressive breast and ovarian cancers,"SAHNI (BRANCATO), JENNIFER",CASE WESTERN RESERVE UNIVERSITY,OH,"$34,398"
Ovarian Cancer,2016,NCI,1F99CA212470-01,,FOXM1-RHNO1 Oncogenic Axis in Ovarian Cancer,"BARGER, CARTER",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$32,771"
Ovarian Cancer,2016,NCI,4R00CA175292-03,,Targeting Determinants of OvCa Metastases in Engineered 3D Microfluidic Platforms,"RIZVI, IMRAN",MASSACHUSETTS GENERAL HOSPITAL,MA,"$249,000"
Ovarian Cancer,2016,NIBIB,1R01EB022033-01A1,,Engineering an immuno-isolating hydrogel for restoring ovarian endocrine function,"SHIKANOV, ARIELLA",UNIVERSITY OF MICHIGAN,MI,"$374,475"
Ovarian Cancer,2016,NCI,3UM1CA173642-04S2,,Relationships between guideline-concordant treatment and survival following an endometrial cancer diagnosis in the Life and Longevity After Cancer Study,"ANDERSON, GARNET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$116,303"
Ovarian Cancer,2016,NCI,7R01CA136494-08,,Molecular Mechanism of Antiangiogenic Properties of Gold Nanoparticle,"MUKHERJEE, PRIYABRATA",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$188,344"
Ovarian Cancer,2016,NCI,3R01CA135354-06S1,,"Supplement to CA135354 ""ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer""","BAST, ROBERT",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$99,082"
Ovarian Cancer,2016,NIGMS,3R01GM113940-03S1,,NIR-activatable Prodrugs for Treating Peritoneally Metastasized Ovarian Cancers,"YOU, YOUNGJAE",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$128,900"
Ovarian Cancer,2016,NCI,7U01CA194393-02,,Quantifying and Characterizing the shared genetic contribution to common cancers,"LINDSTROEM, SARA",UNIVERSITY OF WASHINGTON,WA,"$664,391"
Ovarian Cancer,2016,NCI,3P50CA159981-04S1,,RPCI-UPCI Ovarian Cancer SPORE,"ODUNSI, KUNLE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$66,758"
Ovarian Cancer,2016,NCI,7R01CA178535-04,,The contribution of rare alleles to ovarian cancer in the population,"GAYTHER, SIMON",CEDARS-SINAI MEDICAL CENTER,CA,"$617,338"
Ovarian Cancer,2016,NCI,261201500011C-2-0-1,,IGF::OT::IGF TITLE: VITA-CAP TUBE TO PRESERVE CIRCULATING TUMOR CELLS IN BLOOD.,"CHEN, PH.D., WEN-TIEN","VITATEX, INC.",NY,"$1,952,181"
Ovarian Cancer,2016,NIGMS,7R01GM113940-03,,NIR-activatable Prodrugs for Treating Peritoneally Metastasized Ovarian Cancers,"YOU, YOUNGJAE",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$194,804"
Ovarian Cancer,2016,NCI,7R03CA191447-02,,Validation and Clinical Relevance of Ovarian Cancer Molecular Subtypes,"WALDRON, LEVI",GRADUATE SCHOOL OF PUBLIC HEALTH AND HEALTH POLICY,NY,"$81,250"
Ovarian Cancer,2016,NCI,3U24CA160036-05S1,,Proteome Characterization Center: A Genoproteomics Pipeline for Cance Research,"CHAN, DANIEL",JOHNS HOPKINS UNIVERSITY,MD,"$1,307,657"
Ovarian Cancer,2016,RMAP,3UH3TR000943-04S1,,Novel extra cellular RNA-based combinatorial RNA inhibition therapy,"SOOD, ANIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$80,000"
Ovarian Cancer,2016,NCI,7R01CA194064-02,,Combination Therapy of OvCA with Oligonucleotides and Photodynamic Therapy,"MING, XIN",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$193,994"
Ovarian Cancer,2016,NIGMS,3R35GM118175-01S1,,Fluorescence microscopy for proposed research in the parent grant,"JASIN, MARIA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$176,909"
Ovarian Cancer,2016,NCI,4R44CA203350-02,,Genetic Cytology for Ovarian and Endometrial Cancer Screening,"KINDE, ISAAC","PAPGENE, INC.",MD,"$989,879"
Ovarian Cancer,2016,NCI,7R01CA200231-02,,PHARMACOLOGICAL MODULATION OF POLY(ADP-RIBOSE) METABOLISM,"TAINER, JOHN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$331,714"
Ovarian Cancer,2016,NCI,3U54CA096300-14S1,,UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2),"LOPEZ-BERESTEIN, GABRIEL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$72,364"
Ovarian Cancer,2016,NCI,3U54CA096297-14S1,,UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2),"CRUZ-CORREA, MARCIA",UNIVERSITY OF PUERTO RICO MED SCIENCES,PR,"$217,227"
Ovarian Cancer,2016,NCI,3P50CA159981-04S2,,RPCI-UPCI Ovarian Cancer SPORE,"ODUNSI, KUNLE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$550,298"
Ovarian Cancer,2016,NCI,1ZIACP010126-21,,Hormone-Related Cancers,"BENSON, GRETCHEN",NIH,,"$4,616,752"
Ovarian Cancer,2016,NCI,1ZIACP010128-21,,Therapeutic and Diagnostic Factors as Related to Cancer Risk,"TRABERT, BRITTON",NIH,,"$206,904"
Ovarian Cancer,2016,NCI,1ZIACP010142-18,,Genetic Modifiers of Cancer Risk,"SAVAGE, SHARON",NIH,,"$517,754"
Ovarian Cancer,2016,NCI,1ZIACP010144-18,,Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"SAVAGE, SHARON",NIH,,"$9,672,204"
Ovarian Cancer,2016,NCI,1ZIACP010145-17,,Intervention Trials in Persons at Increased Genetic Risk of Cancer,"SAVAGE, SHARON",NIH,,"$500,914"
Ovarian Cancer,2016,NCI,1ZIACP010152-17,,PLCO Trial Etiologic and Early Marker Study,"HOOVER, ROBERT",NIH,,"$2,752,961"
Ovarian Cancer,2016,NCI,1ZIACP010182-14,,Epidemiologic Field Studies,"GAIL, MITCHELL",NIH,,"$342,731"
Ovarian Cancer,2016,NCI,1ZIACP010187-12,,Cancer Genetic Markers of Susceptibility,"HOOVER, ROBERT",NIH,,"$169,781"
Ovarian Cancer,2016,NCI,1ZIACP010200-09,,GEI - Genome-Wide Association Studies,"CAPORASO, NEIL",NIH,,"$270,176"
Ovarian Cancer,2016,NCI,1ZIACP010207-07,,PLCO EEMS and Extended Follow Up,"HOOVER, ROBERT",NIH,,"$706,495"
Ovarian Cancer,2016,NCI,1ZIABC005445-32,,Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,"YUSPA, STUART",NIH,,"$1,194,199"
Ovarian Cancer,2016,NCI,1ZIABC006161-33,,DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs,"POMMIER, YVES",NIH,,"$980,918"
Ovarian Cancer,2016,NCI,1ZIABC009052-27,,Papillomavirus Virion Proteins and Vaccines,"SCHILLER, JOHN",NIH,,"$2,043,490"
Ovarian Cancer,2016,NCI,1ZIABC010283-19,,DNA repair,"NUSSENZWEIG, ANDRE",NIH,,"$1,428,454"
Ovarian Cancer,2016,NCI,1ZIABC010627-13,,Clinical Pharmacogenetics,"FIGG, WILLIAM",NIH,,"$755,672"
Ovarian Cancer,2016,NCI,1ZIABC010657-12,,Cellular In vivo Imaging,"CHOYKE, PETER",NIH,,"$963,353"
Ovarian Cancer,2016,NCI,1ZIABC010661-12,,Vaccine and Drug Combination Therapy for Human Cancers,"HODGE, JAMES",NIH,,"$573,692"
Ovarian Cancer,2016,NCI,1ZIABC010830-10,,Mechanisms of non-classical multidrug resistance in cancer,"GOTTESMAN, MICHAEL",NIH,,"$1,416,959"
Ovarian Cancer,2016,NCI,1ZIABC010973-09,,Analyses of human T regulatory cells,"TSANG, KWONG YOK",NIH,,"$617,092"
Ovarian Cancer,2016,NCI,1ZIABC011054-09,,Nuclear Factor-kappaB in Ovarian Cancer,"ANNUNZIATA, CHRISTINA",NIH,,"$895,338"
Ovarian Cancer,2016,NCI,1ZIABC011055-09,,Serum Antibody Profiling with a Carbohydrate Microarray,"GILDERSLEEVE, JEFF",NIH,,"$423,701"
Ovarian Cancer,2016,NCI,1ZIABC011311-07,,Identification of genetic interactors of Brca2,"SHARAN, SHYAM",NIH,,"$725,148"
Ovarian Cancer,2016,NCI,1ZIABC011315-07,,Molecular characterization of endometrial cancer,"ANNUNZIATA, CHRISTINA",NIH,,"$59,689"
Ovarian Cancer,2016,NCI,1ZIABC011525-04,,Leveraging DNA damage repair pathways as therapeutic targets in womens cancers,"LEE, JUNG-MIN",NIH,,"$597,694"
Ovarian Cancer,2016,NCI,1ZIABC011584-03,,Clinical trials in womens cancers,"ANNUNZIATA, CHRISTINA",NIH,,"$238,757"
Ovarian Cancer,2016,NCI,1ZIABC011737-01,,"Validation of, and therapeutic evaluation in ovarian cancer GEM models","SHARAN, SHYAM",NIH,,"$495,160"
Ovarian Cancer,2016,NCI,1ZIASC006353-34,,Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,"BRECHBIEL, MARTIN",NIH,,"$778,810"
Ovarian Cancer,2016,NICHD,1ZIAHD008804-10,,The Role of Carboxypeptidase E in Cancer,"LOH, YOKE",NIH,,"$609,044"
Ovarian Cancer,2016,NIEHS,1ZIAES044005-18,,Environmental and Genetic Risk Factors For Breast Cancer: The Sister Study,"SANDLER, DALE",NIH,,"$888,330"
Ovarian Cancer,2016,NIAID,1ZIAAI001038-09,,Mechanisms of Antitumor Action of Human Interferon,"ZOON, KATHRYN",NIH,,"$262,190"
Ovarian Cancer,2016,NCATS,1ZIATR000018-02,,Drug Repurposing Screening for Rare and Neglected Diseases,"ZHENG, WEI",NIH,,"$1,292,761"
Ovarian Cancer,2016,NCATS,1ZIATR000268-01,,3D Bioprinting of human native-like tissues as disease-in-a-dish models for drug discovery,"FERRER, MARC",NIH,,"$3,010,693"
Ovarian Cancer,2016,NCI,261201600039C-0-0-1,,IGF::OT::IGF ESTABLISHMENT OF CANCER CELL LINES FOR ADVANCING OVARIAN CANCER HEALTH DISPARITY RESEARCH,"SRIVASTAVA, SANJEEV","TATVA BIOSCIENCES, LLC",AL,"$224,869"
Ovarian Cancer,2016,NHGRI,1ZIAHG200323-12,,"Genomic, Epigenetic and Functional Analyses of Vertebrate Regulatory Regions","ELNITSKI, LAURA",NIH,,"$1,714,348"
Ovarian Cancer,2016,NCI,261201500041I-0-26100003-1,,"IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)AWARD OF TASK ORDER ""OPTIMIZATION AND FURTHER DEVELOPMENT OF MESOTHELIN VACCINE FOR THE PREVENTION OF OVARIAN CANCER""","SCHOLLER, NATHALIE",SRI INTERNATIONAL,CA,"$712,240"
Ovarian Cancer,2016,NHGRI,1ZIAHG000120-20,,The role of the BRCA1 and BRCA2 gene in the pathogenesis of breast cancer,"BRODY, LAWRENCE",NIH,,"$39,630"
Ovarian Cancer,2016,NCATS,1ZIATR000251-01,,qHTS to Identify Inhibitors of NNMT1,"HALL, MATTHEW",NIH,,"$37,474"
Ovarian Cancer,2016,NCATS,1ZIATR000075-02,,High Content Screening using 3-D Models of Ovarian Cancer,"FERRER, MARC",NIH,,"$37,474"
